⇚ Regimen PARAPLATIN® and VEPESID® with IMFINZI® - for Small Cell Lung Cancer Medical Name PARAPLATIN® (Carboplatin) and VEPESID® (Etoposide) along with IMFINZI® (Durvalumab) for Extensive Stage Small Cell Lung Cancer Cycles Given 4 Delivery Phases N/A Special Instructions Administer IMFINZI® prior to chemotherapy when administered on the same day. Monitor patients for Infusion-Related Reactions and Immune-Mediated adverse events. IMFINZI® continued as maintenance treatment every 4 weeks until disease progression or unacceptable toxicities. References Paz-Ares L, et al. Lancet. 2019 - VIEW External References http://www.ncbi.nlm.nih.gov/pubmed/31590988 - VIEW Drug Mode Given Standard Dose Days to Be Given Frequency Solution Volume Duration PARAPLATIN® (Carboplatin) IV AUC 5 D1 q21 NSS 250 cc 60 minutes VEPESID® (Etoposide) IV 100 mg/m2 D1, D2, D3 q21 NSS 500 cc 90 minutes IMFINZI® (Durvalumab) IV 1500 mg D1 q21 NSS 250 cc 60 minutes